Barclays Global Investors (BGI), one of the world's largest institutional asset managers and Exchange Traded Funds (ETF) managers, today announced the transfer of the iShares Nasdaq Biotechnology Index Fund (ticker: IBB) from the American Stock Exchange to The NASDAQ Stock Market and the move of the iShares S&P 100 Index Fund (ticker: OEF) from the Chicago Board Options Exchange to the NYSE Arca listing and trading platform on September 23, 2008. Current shareholders are not required to take any actions as a result of these changes.
"The natural listing location of the iShares Nasdaq Biotechnology Index Fund is The NASDAQ and the transfer of the iShares S&P 100 Index Fund to the NYSE Arca is logical as well since it is joining the other iShares S&P Funds," said Michael Latham, CEO of U.S. iShares at Barclays Global Investors. "We appreciate The NASDAQ and the NYSE Arca's support of the ETF marketplace."
The iShares Funds are index funds that are bought and sold like common stocks on securities exchanges. The iShares Funds are attractive to many individual and institutional investors and financial intermediaries because of their relative low cost, tax efficiency and trading flexibility. Investors can purchase and sell shares through any brokerage firm, financial advisor, or online broker, and hold the funds in any type of brokerage account.
Tuesday, 2 September 2008
BGI Moves ETFs Exchanges
Subscribe to:
Post Comments (Atom)
1 comment:
Thanks for making my morning a little bit better with this great article!!
ecl stock
Post a Comment